Global Rotavirus Vaccine Market Growth 2020-2025

November 2020 | 137 pages | ID: GFF47EC9E05AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, over the next five years the Rotavirus Vaccine market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Rotavirus Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Rotavirus Vaccine, covering the supply chain analysis, impact assessment to the Rotavirus Vaccine market size growth rate in several scenarios, and the measures to be undertaken by Rotavirus Vaccine companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

• Pentavalent
• Oral

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

• Government Institution
• Private Sector
• Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• Merck
• GSK
• Lanzhou Institution
• Sanofi

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Rotavirus Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Rotavirus Vaccine market by identifying its various subsegments.
• Focuses on the key global Rotavirus Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Rotavirus Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Rotavirus Vaccine submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Rotavirus Vaccine Consumption 2015-2025
  2.1.2 Rotavirus Vaccine Consumption CAGR by Region
2.2 Rotavirus Vaccine Segment by Type
  2.2.1 Pentavalent
  2.2.2 Oral
2.3 Rotavirus Vaccine Consumption by Type
  2.3.1 Global Rotavirus Vaccine Consumption Market Share by Type (2015-2020)
  2.3.2 Global Rotavirus Vaccine Revenue and Market Share by Type (2015-2020)
  2.3.3 Global Rotavirus Vaccine Sale Price by Type (2015-2020)
2.4 Rotavirus Vaccine Segment by Application
  2.4.1 Government Institution
  2.4.2 Private Sector
  2.4.3 Other
2.5 Rotavirus Vaccine Consumption by Application
  2.5.1 Global Rotavirus Vaccine Consumption Market Share by Type (2015-2020)
  2.5.2 Global Rotavirus Vaccine Value and Market Share by Type (2015-2020)
  2.5.3 Global Rotavirus Vaccine Sale Price by Type (2015-2020)

3 GLOBAL ROTAVIRUS VACCINE BY COMPANY

3.1 Global Rotavirus Vaccine Sales Market Share by Company
  3.1.1 Global Rotavirus Vaccine Sales by Company (2018-2020)
  3.1.2 Global Rotavirus Vaccine Sales Market Share by Company (2018-2020)
3.2 Global Rotavirus Vaccine Revenue Market Share by Company
  3.2.1 Global Rotavirus Vaccine Revenue by Company (2018-2020)
  3.2.2 Global Rotavirus Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global Rotavirus Vaccine Sale Price by Company
3.4 Global Rotavirus Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
  3.4.1 Global Rotavirus Vaccine Manufacturing Base Distribution and Sales Area by Company
  3.4.2 Players Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ROTAVIRUS VACCINE BY REGIONS

4.1 Rotavirus Vaccine by Regions
4.2 Americas Rotavirus Vaccine Consumption Growth
4.3 APAC Rotavirus Vaccine Consumption Growth
4.4 Europe Rotavirus Vaccine Consumption Growth
4.5 Middle East & Africa Rotavirus Vaccine Consumption Growth

5 AMERICAS

5.1 Americas Rotavirus Vaccine Consumption by Countries
  5.1.1 Americas Rotavirus Vaccine Consumption by Countries (2015-2020)
  5.1.2 Americas Rotavirus Vaccine Value by Countries (2015-2020)
5.2 Americas Rotavirus Vaccine Consumption by Type
5.3 Americas Rotavirus Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Rotavirus Vaccine Consumption by Regions
  6.1.1 APAC Rotavirus Vaccine Consumption by Regions (2015-2020)
  6.1.2 APAC Rotavirus Vaccine Value by Regions (2015-2020)
6.2 APAC Rotavirus Vaccine Consumption by Type
6.3 APAC Rotavirus Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 EUROPE

7.1 Europe Rotavirus Vaccine by Countries
  7.1.1 Europe Rotavirus Vaccine Consumption by Countries (2015-2020)
  7.1.2 Europe Rotavirus Vaccine Value by Countries (2015-2020)
7.2 Europe Rotavirus Vaccine Consumption by Type
7.3 Europe Rotavirus Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Rotavirus Vaccine by Countries
  8.1.1 Middle East & Africa Rotavirus Vaccine Consumption by Countries (2015-2020)
  8.1.2 Middle East & Africa Rotavirus Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa Rotavirus Vaccine Consumption by Type
8.3 Middle East & Africa Rotavirus Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Channels
  10.1.2 Indirect Channels
10.2 Rotavirus Vaccine Distributors
10.3 Rotavirus Vaccine Customer

11 GLOBAL ROTAVIRUS VACCINE MARKET FORECAST

11.1 Global Rotavirus Vaccine Consumption Forecast (2021-2025)
11.2 Global Rotavirus Vaccine Forecast by Regions
  11.2.1 Global Rotavirus Vaccine Forecast by Regions (2021-2025)
  11.2.2 Global Rotavirus Vaccine Value Forecast by Regions (2021-2025)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Rotavirus Vaccine Forecast by Type
11.8 Global Rotavirus Vaccine Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Merck
  12.1.1 Company Information
  12.1.2 Rotavirus Vaccine Product Offered
  12.1.3 Merck Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
  12.1.4 Main Business Overview
  12.1.5 Merck Latest Developments
12.2 GSK
  12.2.1 Company Information
  12.2.2 Rotavirus Vaccine Product Offered
  12.2.3 GSK Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
  12.2.4 Main Business Overview
  12.2.5 GSK Latest Developments
12.3 Lanzhou Institution
  12.3.1 Company Information
  12.3.2 Rotavirus Vaccine Product Offered
  12.3.3 Lanzhou Institution Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
  12.3.4 Main Business Overview
  12.3.5 Lanzhou Institution Latest Developments
12.4 Sanofi
  12.4.1 Company Information
  12.4.2 Rotavirus Vaccine Product Offered
  12.4.3 Sanofi Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
  12.4.4 Main Business Overview
  12.4.5 Sanofi Latest Developments

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Research Methodology
Table 2. Data Source
Table 3. Rotavirus Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Pentavalent
Table 5. Major Players of Oral
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Rotavirus Vaccine Consumption Market Share by Type (2015-2020)
Table 8. Global Rotavirus Vaccine Revenue by Type (2015-2020) ($ million)
Table 9. Global Rotavirus Vaccine Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Rotavirus Vaccine Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Rotavirus Vaccine Consumption Market Share by Application (2015-2020)
Table 13. Global Rotavirus Vaccine Value by Application (2015-2020)
Table 14. Global Rotavirus Vaccine Value Market Share by Application (2015-2020)
Table 15. Global Rotavirus Vaccine Sale Price by Application (2015-2020)
Table 16. Global Rotavirus Vaccine Sales by Company (2017-2019) (K Units)
Table 17. Global Rotavirus Vaccine Sales Market Share by Company (2017-2019)
Table 18. Global Rotavirus Vaccine Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Rotavirus Vaccine Revenue Market Share by Company (2017-2019)
Table 20. Global Rotavirus Vaccine Sale Price by Company (2017-2019)
Table 21. Global Rotavirus Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Rotavirus Vaccine Products Offered
Table 23. Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Rotavirus Vaccine Consumption by Regions 2015-2020 (K Units)
Table 25. Global Rotavirus Vaccine Consumption Market Share by Regions 2015-2020
Table 26. Global Rotavirus Vaccine Value by Regions 2015-2020 ($ Millions)
Table 27. Global Rotavirus Vaccine Value Market Share by Regions 2015-2020
Table 28. Americas Rotavirus Vaccine Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Rotavirus Vaccine Consumption Market Share by Countries (2015-2020)
Table 30. Americas Rotavirus Vaccine Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Rotavirus Vaccine Value Market Share by Countries (2015-2020)
Table 32. Americas Rotavirus Vaccine Consumption by Type (2015-2020) (K Units)
Table 33. Americas Rotavirus Vaccine Consumption Market Share by Type (2015-2020)
Table 34. Americas Rotavirus Vaccine Consumption by Application (2015-2020) (K Units)
Table 35. Americas Rotavirus Vaccine Consumption Market Share by Application (2015-2020)
Table 36. APAC Rotavirus Vaccine Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Rotavirus Vaccine Consumption Market Share by Regions (2015-2020)
Table 38. APAC Rotavirus Vaccine Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Rotavirus Vaccine Value Market Share by Regions (2015-2020)
Table 40. APAC Rotavirus Vaccine Consumption by Type (2015-2020) (K Units)
Table 41. APAC Rotavirus Vaccine Consumption Market Share by Type (2015-2020)
Table 42. APAC Rotavirus Vaccine Consumption by Application (2015-2020) (K Units)
Table 43. APAC Rotavirus Vaccine Consumption Market Share by Application (2015-2020)
Table 44. Europe Rotavirus Vaccine Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Rotavirus Vaccine Consumption Market Share by Countries (2015-2020)
Table 46. Europe Rotavirus Vaccine Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Rotavirus Vaccine Value Market Share by Countries (2015-2020)
Table 48. Europe Rotavirus Vaccine Consumption by Type (2015-2020) (K Units)
Table 49. Europe Rotavirus Vaccine Consumption Market Share by Type (2015-2020)
Table 50. Europe Rotavirus Vaccine Consumption by Application (2015-2020) (K Units)
Table 51. Europe Rotavirus Vaccine Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Rotavirus Vaccine Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Rotavirus Vaccine Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Rotavirus Vaccine Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Rotavirus Vaccine Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Rotavirus Vaccine Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Rotavirus Vaccine Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Rotavirus Vaccine Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Rotavirus Vaccine Consumption Market Share by Application (2015-2020)
Table 60. Rotavirus Vaccine Distributors List
Table 61. Rotavirus Vaccine Customer List
Table 62. Global Rotavirus Vaccine Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Rotavirus Vaccine Consumption Market Forecast by Regions
Table 64. Global Rotavirus Vaccine Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Rotavirus Vaccine Value Market Share Forecast by Regions
Table 66. Global Rotavirus Vaccine Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Rotavirus Vaccine Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Rotavirus Vaccine Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Rotavirus Vaccine Value Market Share Forecast by Type (2021-2025)
Table 70. Global Rotavirus Vaccine Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Rotavirus Vaccine Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Rotavirus Vaccine Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Rotavirus Vaccine Value Market Share Forecast by Application (2021-2025)
Table 74. Merck Product Offered
Table 75. Merck Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Merck Basic Information, Company Total Revenue (in $ million), Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Product Offered
Table 80. GSK Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. GSK Basic Information, Company Total Revenue (in $ million), Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Lanzhou Institution Product Offered
Table 85. Lanzhou Institution Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Lanzhou Institution Main Business
Table 87. Lanzhou Institution Latest Developments
Table 88. Lanzhou Institution Basic Information, Company Total Revenue (in $ million), Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Product Offered
Table 90. Sanofi Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Sanofi Basic Information, Company Total Revenue (in $ million), Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Rotavirus Vaccine
Figure 2. Rotavirus Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Rotavirus Vaccine Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Rotavirus Vaccine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Pentavalent
Figure 7. Product Picture of Oral
Figure 8. Global Rotavirus Vaccine Consumption Market Share by Type (2015-2020)
Figure 9. Global Rotavirus Vaccine Value Market Share by Type (2015-2020)
Figure 10. Rotavirus Vaccine Consumed in Government Institution
Figure 11. Global Rotavirus Vaccine Market: Government Institution (2015-2020) (K Units)
Figure 12. Global Rotavirus Vaccine Market: Government Institution (2015-2020) ($ Millions)
Figure 13. Rotavirus Vaccine Consumed in Private Sector
Figure 14. Global Rotavirus Vaccine Market: Private Sector (2015-2020) (K Units)
Figure 15. Global Rotavirus Vaccine Market: Private Sector (2015-2020) ($ Millions)
Figure 16. Rotavirus Vaccine Consumed in Other
Figure 17. Global Rotavirus Vaccine Market: Other (2015-2020) (K Units)
Figure 18. Global Rotavirus Vaccine Market: Other (2015-2020) ($ Millions)
Figure 19. Global Rotavirus Vaccine Consumption Market Share by Application (2015-2020)
Figure 20. Global Rotavirus Vaccine Value Market Share by Application (2015-2020)
Figure 21. Global Rotavirus Vaccine Sales Market Share by Company in 2017
Figure 22. Global Rotavirus Vaccine Sales Market Share by Company in 2019
Figure 23. Global Rotavirus Vaccine Revenue Market Share by Company in 2017
Figure 24. Global Rotavirus Vaccine Revenue Market Share by Company in 2019
Figure 25. Global Rotavirus Vaccine Sale Price by Company in 2019
Figure 26. Global Rotavirus Vaccine Consumption Market Share by Regions 2015-2020
Figure 27. Global Rotavirus Vaccine Value Market Share by Regions 2015-2020
Figure 28. Americas Rotavirus Vaccine Consumption 2015-2020 (K Units)
Figure 29. Americas Rotavirus Vaccine Value 2015-2020 ($ Millions)
Figure 30. APAC Rotavirus Vaccine Consumption 2015-2020 (K Units)
Figure 31. APAC Rotavirus Vaccine Value 2015-2020 ($ Millions)
Figure 32. Europe Rotavirus Vaccine Consumption 2015-2020 (K Units)
Figure 33. Europe Rotavirus Vaccine Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Rotavirus Vaccine Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Rotavirus Vaccine Value 2015-2020 ($ Millions)
Figure 36. Americas Rotavirus Vaccine Consumption Market Share by Countries in 2019
Figure 37. Americas Rotavirus Vaccine Value Market Share by Countries in 2019
Figure 38. Americas Rotavirus Vaccine Consumption Market Share by Type in 2019
Figure 39. Americas Rotavirus Vaccine Consumption Market Share by Application in 2019
Figure 40. United States Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 41. United States Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Rotavirus Vaccine Consumption Market Share by Countries in 2019
Figure 47. APAC Rotavirus Vaccine Value Market Share by Regions in 2019
Figure 48. APAC Rotavirus Vaccine Consumption Market Share by Type in 2019
Figure 49. APAC Rotavirus Vaccine Consumption Market Share by Application in 2019
Figure 50. China Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 51. China Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 58. India Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 59. India Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Rotavirus Vaccine Consumption Market Share by Countries in 2019
Figure 63. Europe Rotavirus Vaccine Value Market Share by Countries in 2019
Figure 64. Europe Rotavirus Vaccine Consumption Market Share by Type in 2019
Figure 65. Europe Rotavirus Vaccine Consumption Market Share by Application in 2019
Figure 66. Germany Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 68. France Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 69. France Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 70. UK Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 71. UK Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Rotavirus Vaccine Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Rotavirus Vaccine Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Rotavirus Vaccine Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Rotavirus Vaccine Consumption Market Share by Application in 2019
Figure 80. Egypt Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Rotavirus Vaccine Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Rotavirus Vaccine Value Growth 2015-2020 ($ Millions)
Figure 90. Global Rotavirus Vaccine Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Rotavirus Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 93. Americas Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 94. APAC Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 95. APAC Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 96. Europe Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 97. Europe Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 100. United States Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 101. United States Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 102. Canada Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 103. Canada Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 104. Mexico Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 105. Mexico Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 106. Brazil Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 107. Brazil Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 108. China Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 109. China Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 110. Japan Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 111. Japan Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 112. Korea Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 113. Korea Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 116. India Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 117. India Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 118. Australia Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 119. Australia Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 120. Germany Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 121. Germany Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 122. France Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 123. France Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 124. UK Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 125. UK Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 126. Italy Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 127. Italy Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 128. Russia Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 129. Russia Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 130. Spain Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 131. Spain Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 132. Egypt Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 133. Egypt Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 134. South Africa Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 135. South Africa Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 136. Israel Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 137. Israel Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 138. Turkey Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 139. Turkey Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Rotavirus Vaccine Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Rotavirus Vaccine Value 2021-2025 ($ Millions)
Figure 142. Merck Rotavirus Vaccine Market Share (2018-2020)
Figure 143. GSK Rotavirus Vaccine Market Share (2018-2020)
Figure 144. Lanzhou Institution Rotavirus Vaccine Market Share (2018-2020)
Figure 145. Sanofi Rotavirus Vaccine Market Share (2018-2020)